French biotech gets funding for universal flu and coronavirus vaccines 09-Jul-2020 By Ben Hargreaves Osivax receives public funding to apply its vaccine technology to protect against COVID-19 and future coronavirus strains.
Operation Warp Speed delivers $2bn to scale COVID-19 solutions 08-Jul-2020 By Ben Hargreaves Novavax is the principle recipient of the funding, as US government provides capital in return for guaranteed access to doses.
Regeneron COVID-19 antibody cocktail enters late-stage trials 07-Jul-2020 By Ben Hargreaves Regeneron’s potential coronavirus treatment enters Phase III and US government provides capital injection for manufacture.
Tesla’s ‘side project’ building RNA microfactories for CureVac 03-Jul-2020 By Ben Hargreaves Elon Musk revealed the news on Twitter that Tesla was working with CureVac and ‘possibly others’ to produce RNA vaccines.
Takeda expands in gene therapy with $900m R&D deal 02-Jul-2020 By Ben Hargreaves Takeda signs R&D agreement with Carmine for the development of two non-viral gene therapies.
Pfizer posts positive vaccine results and capacity for 1.2bn doses 02-Jul-2020 By Ben Hargreaves Pfizer and BioNTech release positive results from Phase I/II trials investigating their mRNA vaccine against COVID-19.
FDA says COVID-19 vaccine must be effective in half of recipients 01-Jul-2020 By Ben Hargreaves US FDA demands that vaccine must prevent or decrease severity in at least 50% of people receiving doses.
BioNTech receives $250m investment amid vaccine development 30-Jun-2020 By Staff Reporter June sees BioNTech secure hundreds of millions in investment to progress pipeline, including mRNA COVID-19 vaccine.
CSL Behring in $450m spend on hemophilia gene therapy 30-Jun-2020 By Ben Hargreaves The company buys the global rights to a gene therapy currently going through Phase III trials.
Inovio posts positive COVID-19 vaccine results but few details 30-Jun-2020 By Ben Hargreaves The biotech reveals positive results of Phase I trials but does not provide a fuller picture of data.
Moderna secures fill-finish capabilities for COVID-19 vaccine 29-Jun-2020 By Ben Hargreaves Moderna signs deal with Catalent for fill-finish services, shortly after AZ announced the same move.
WHO seeks $31bn in next 18 months to combat COVID-19 29-Jun-2020 By Ben Hargreaves The organization wants to raise the sum to support its ‘three pillar’ approach to the pandemic: vaccines, therapeutics, and diagnostics.
AstraZeneca makes another vaccine supply agreement 25-Jun-2020 By Ben Hargreaves AZ enters a supply agreement with Symbiosis as it continues to work on bolstering supply for its COVID-19 vaccine.
Hired & Retired: From big pharma to mid-sized leadership 24-Jun-2020 By Ben Hargreaves This month featured executives making the switch from big pharma to take on leadership positions at mid-sized companies.
Gilead continues small deal spree 23-Jun-2020 By Ben Hargreaves Gilead buys a stake in Pionyr and holds the option to acquire the biotech outright.
